

29 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-to-announce-q3-2025-financial-results--company-update-302597189.html

20 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cumberland-phamaceuticals-announces-the-addition-of-an-established-fda-approved-product-to-its-commercial-portfolio-302588788.html

29 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tabuk-launches-vibativ-fda-approved-antibiotic-with-life-saving-potential-in-saudi-arabia-302568865.html

04 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-receives-vizient-contract-for-new-vibativ-4-vial-starter-pak-302520440.html

26 May 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-publication-reveals-real-world-usage-of-vibativ-in-patients-with-bacteremia-or-endocarditis-301064062.html

11 May 2020
// PHARMIWEB
https://www.pharmiweb.com/press-release/2020-05-11/vibativ-sustained-potency-confirmed-in-two-surveillance-studies